Heart rhythm
October 19, 2026 Β· via Europe PMC
High-Frequency Electrograms Abolition as a Valuable Target for Remap During Ventricular Tachycardia Ablation. The HF REMAP Study.
Cauti FM, Valente D, Magnocavallo M, +11 more, Della Bella P.
AI summary β for doctors, generated from the abstract only
Residual high-frequency electrograms predicted VT recurrence.
What was studied
Retrospective study of 43 VT ablation patients.
Key findings
- 11 events during 372 days.
- Low residual burden linked to better survival.
- Abstract truncated.
Clinical relevance
Possible objective endpoint.
Who should care
Limitations
Small retrospective, abstract truncated.
Await validation.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates β verify against the original source before acting on it.
Abstract
Background
peak frequency (PF) analysis has recently emerged as a novel tool to assess electrogram properties through their frequency spectrum. PF is an indirect marker of local myocardial activity, and its reduction after radiofrequency ablation reflects effective tissue modification.
Objective
our study aims to evaluate PF analysis as an objective method to validate lesion efficacy during ventricular tachycardia (VT) ablation.
Methods
we retrospectively analyzed 43 (out of 247) consecutive patients who underwent VT ablation between January 2023 and December 2024, using the EnSite X mapping system with Advisor HD Grid catheter (Abbott, Minneapolis, USA). Complete pre- and post-ablation high-density sinus rhythm maps were obtained. PF analysis was applied offline to quantify the residual high-frequency (HF) electrogram burden, expressed as a percentage of the ablated area. Patients were stratified according to residual HF burden, and outcomes were assessed with Kaplan-Meier survival analysis and Cox regression analysis.
Results
During a median follow-up of 372 days, 11 patients reached the primary endpoint (VT recurrence or arrhythmic storm). Patients with <70% residual HF post-ablation had significantly higher VT-free survival (β90% at 12 months) compared to those with β₯70% residual HF (β25%; log-rank p<0.001). Cox regression confirmed residual HF β₯70% as an independent predictor of recurrence (HR 13.36; 95% CI 3.52-50.7; p<0.001).
Conclusion
PF analysis during re-mapping provides an operator-independent, reproducible tool to validate lesion efficacy. A low post-ablation residual HF burden is associated to a significantly increased VAs-free survival rate.
DOI
10.1016/j.hrthm.2026.10.020
PMID
42896744
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed